Characterization of the p53-dependent postmitotic checkpoint following spindle disruption.

Molecular and Cellular Biology
J S Lanni, Tyler Jacks

Abstract

The p53 tumor suppressor gene product is known to act as part of a cell cycle checkpoint in G1 following DNA damage. In order to investigate a proposed novel role for p53 as a checkpoint at mitosis following disruption of the mitotic spindle, we have used time-lapse videomicroscopy to show that both p53+/+ and p53-/- murine fibroblasts treated with the spindle drug nocodazole undergo transient arrest at mitosis for the same length of time. Thus, p53 does not participate in checkpoint function at mitosis. However, p53 does play a critical role in nocodazole-treated cells which have exited mitotic arrest without undergoing cytokinesis and have thereby adapted. We have determined that in nocodazole-treated, adapted cells, p53 is required during a specific time window to prevent cells from reentering the cell cycle and initiating another round of DNA synthesis. Despite having 4N DNA content, adapted cells are similar to G1 cells in that they have upregulated cyclin E expression and hypophosphorylated Rb protein. The mechanism of the p53-dependent arrest in nocodazole-treated adapted cells requires the cyclin-dependent kinase inhibitor p21, as p21-/- fibroblasts fail to arrest in response to nocodazole treatment and become polyploid...Continue Reading

References

Aug 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·S J KuerbitzM B Kastan
Apr 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·A HemerlyP Ferreira
May 8, 1992·Science·S E KernB Vogelstein
Jul 2, 1992·Nature·G FarmerC Prives
Aug 9, 1991·Cell·R Li, A W Murray
Dec 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·A L KungR T Schimke
Oct 12, 1995·Nature·J BrugarolasG J Hannon
Mar 3, 1995·Science·S M CrossB J Reid
Jan 1, 1994·Current Biology : CB·T JacksR A Weinberg
Jul 1, 1994·Journal of Cellular Physiology·C R BrownW J Welch
Sep 30, 1994·Science·H Hermeking, D Eick
Nov 19, 1993·Cell·W S el-DeiryB Vogelstein
Dec 16, 1993·Nature·Y XiongD Beach
Jan 1, 1993·Molecular and Cellular Biology·J W LudlowJ A DeCarprio
Mar 22, 1996·Science·K FukasawaG F Vande Woude
Oct 11, 1996·Science·Y Li, R Benezra
Dec 1, 1996·Current Opinion in Cell Biology·A D Rudner, A W Murray
Dec 6, 1996·Science·C J Sherr
Feb 7, 1997·Cell·A G PaulovichL H Hartwell

❮ Previous
Next ❯

Citations

Dec 10, 2015·Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology·Marco Raffaele Cosenza, Alwin Krämer
Jan 14, 2012·Expert Opinion on Therapeutic Targets·Alexander H Stegh
Dec 12, 2012·The Journal of Cell Biology·Neil J Ganem, David Pellman
Apr 29, 2015·The Journal of Cell Biology·Yihan WanYixian Zheng
Oct 4, 2005·Expert Opinion on Biological Therapy·Bela BodeyStuart E Siegel
Mar 8, 2000·Cancer Investigation·P Tarapore, K Fukasawa
Jan 19, 2016·Frontiers in Oncology·Antonino B D'AssoroEvanthia Galanis
Jan 30, 2004·International Journal of Cancer. Journal International Du Cancer·Stefan Duensing, Karl Münger
Dec 3, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Asta Bjork JonsdottirJorunn E Eyfjord
Aug 23, 2002·Neoplasia : an International Journal for Oncology Research·Laura LentiniAldo Di Leonardo
Mar 15, 2011·Biochemical and Biophysical Research Communications·Mai TsuchiyaJunn Yanagisawa
Oct 19, 2011·Pathology Research International·Alfonso BaldiGennaro Citro
Jan 24, 2009·Biochemical and Biophysical Research Communications·Anca Bene, Timothy C Chambers
Jan 24, 2009·Critical Reviews in Oncology/hematology·Anil K Panigrahi, Debananda Pati
May 13, 2008·Biochimica Et Biophysica Acta·Saskia J E Suijkerbuijk, Geert J P L Kops
Aug 3, 2007·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Mathias Schmidt, Holger Bastians
Aug 21, 2015·Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP·Fanxing ZengNiels C Bols
Jul 12, 2008·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Susumu Ohshima
Jun 10, 2014·Molecular Cell·Yoshikazu JohmuraMakoto Nakanishi
Jun 19, 2008·Journal of Biochemical and Molecular Toxicology·Kent Carlson, Marion Ehrich
Oct 11, 2011·The Journal of Pathology·Benjamin Lacroix, Amy Shaub Maddox
Oct 19, 2011·Journal of Cellular Biochemistry·Walter Hanel, Ute M Moll
Apr 29, 2014·Pigment Cell & Melanoma Research·Hun-Way HwangWilliam J Pavan
May 4, 2005·Biochemical and Biophysical Research Communications·Anette Duensing, Stefan Duensing
Jan 13, 2011·Biochimica Et Biophysica Acta·António Pedro GonçalvesArnaldo Videira
Apr 24, 2002·Toxicology and Applied Pharmacology·J Christopher StatesMichael J McCabe
Jul 29, 2004·DNA Repair·Ciaran Morrison, Conly L Rieder
Feb 11, 2005·Journal of Chemotherapy·D T BergstralhJ P Y Ting
May 4, 2005·Trends in Cell Biology·Régis GietClaude Prigent
Aug 20, 2011·Molecular Oncology·Yael Aylon, Moshe Oren
May 25, 2002·Experimental Cell Research·Steven P AngusErik S Knudsen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.